AMIDEBIO, LLC — Department of Health and Human Services SBIR Phase I: 200
AMIDEBIO, LLC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $338,388
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 200
- Solicitation
- PA16-302
- NAICS
- —
- Place of performance
- CO
- Period
- 2017-09-18 → 2019-08-31
Description
SUMMARY ABSTRACT A series of glucagon analogues will be designedproduced at milligram levelstested for solution stability and both in vitro and in vivo activity with the goal of providing a long term treatment for hyperinsulinism